Using physical activity and relaxation techniques to reduce anxiety in ICU patients with blood cancers
Adapted Physical Activity and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in Intensive Care unit_APAER_H Protocol
This study is testing if physical activity and relaxation techniques can help reduce anxiety in ICU patients with blood cancers.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Régional Metz-Thionville Academic / other |
| Locations | 1 site (Metz) |
| Trial ID | NCT05475600 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of Adapted Physical Activity (APA) programs, including traditional exercises, Exergaming, and biofeedback relaxation, on anxiety levels in patients with hematological malignancies admitted to the Intensive Care Unit (ICU). The research aims to determine whether these interventions can help maintain functional capacities and improve psychological well-being during hospital stays. By integrating supportive care strategies, the study seeks to address the physical and emotional challenges faced by these patients, particularly in reducing anxiety and enhancing quality of life.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 75 who are admitted to the ICU with hematological malignancies.
Not a fit: Patients who have contraindications for physical exercise or are unable to understand the French language may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce anxiety and improve the overall quality of life for patients with severe blood diseases in the ICU.
How similar studies have performed: Other studies have shown promising results with similar approaches using physical activity and relaxation techniques in cancer care, indicating potential for success in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects aged between 18 and 75 years old * Admitted in Intensive Care Unit * Informed consent Exclusion Criteria: * Contraindication for physical exercise * Inability to understand the French language (written and/or oral) * Ongoing involvement in another proprietary research protocol * Lack of affiliation to social security
Where this trial is running
Metz
- CHR Metz-Thionville/Hopital de Mercy — Metz, France (Recruiting)
Study contacts
- Principal investigator: Véronique DORVAUX, MD — CHR Metz Thionville Hopital de Mercy
- Study coordinator: Arpiné EL NAR, PhD
- Email: projet-recherche-clinique@chr-metz-thionville.fr
- Phone: 0033387557766
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.